Acetate coordinates neutrophil and ILC3 responses against <i>C. difficile</i> through FFAR2

  • José Luís Fachi
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Cristiane Sécca
    Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 2
  • Patrícia Brito Rodrigues
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Felipe Cézar Pinheiro de Mato
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Blanda Di Luccia
    Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 2
  • Jaqueline de Souza Felipe
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Laís Passariello Pral
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Marcella Rungue
    Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil 3
  • Victor de Melo Rocha
    Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil 3
  • Fabio Takeo Sato
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1
  • Ulliana Sampaio
    Department of Food Technology, School of Food Engineering, University of Campinas, Campinas, Brazil 4
  • Maria Teresa Pedrosa Silva Clerici
    Department of Food Technology, School of Food Engineering, University of Campinas, Campinas, Brazil 4
  • Hosana Gomes Rodrigues
    Laboratory of Nutrients & Tissue Repair, School of Applied Sciences, University of Campinas, Limeira, Brazil 5
  • Niels Olsen Saraiva Câmara
    Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil 6
  • Sílvio Roberto Consonni
    Department of Biochemistry & Tissue Biology, Institute of Biology, University of Campinas, Campinas, Brazil 7
  • Angélica Thomaz Vieira
    Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil 3
  • Sergio Costa Oliveira
    Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil 3
  • Charles Reay Mackay
    Department of Immunology, Monash University, Melbourne, Australia 8
  • Brian T. Layden
    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Illinois at Chicago, Chicago, IL 9
  • Karina Ramalho Bortoluci
    Center for Cellular and Molecular Therapy, Federal University of São Paulo, Vl Clementino, São Paulo, Brazil 11
  • Marco Colonna
    Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 2
  • Marco Aurélio Ramirez Vinolo
    Laboratory of Immunoinflammation, Department of Genetics and Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, Brazil 1

抄録

<jats:p>Antibiotic-induced dysbiosis is a key predisposing factor for Clostridium difficile infections (CDIs), which cause intestinal disease ranging from mild diarrhea to pseudomembranous colitis. Here, we examined the impact of a microbiota-derived metabolite, short-chain fatty acid acetate, on an acute mouse model of CDI. We found that administration of acetate is remarkably beneficial in ameliorating disease. Mechanistically, we show that acetate enhances innate immune responses by acting on both neutrophils and ILC3s through its cognate receptor free fatty acid receptor 2 (FFAR2). In neutrophils, acetate-FFAR2 signaling accelerates their recruitment to the inflammatory sites, facilitates inflammasome activation, and promotes the release of IL-1β; in ILC3s, acetate-FFAR2 augments expression of the IL-1 receptor, which boosts IL-22 secretion in response to IL-1β. We conclude that microbiota-derived acetate promotes host innate responses to C. difficile through coordinate action on neutrophils and ILC3s.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ